Sebastian Weingärtner1,2,3, Nadja M Meßner1,4, Frank G Zöllner1, Mehmet Akçakaya2,3, Lothar R Schad1. 1. Computer Assisted Clinical Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany. 2. Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota, United States. 3. Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, United States. 4. DZHK (German Centre for Cardiovascular Research) partner site Mannheim, Germany.
Abstract
PURPOSE: To study the feasibility of black-blood contrast in native T1 mapping for reduction of partial voluming at the blood-myocardium interface. METHODS: A saturation pulse prepared heart-rate-independent inversion recovery (SAPPHIRE) T1 mapping sequence was combined with motion-sensitized driven-equilibrium (MSDE) blood suppression for black-blood T1 mapping at 3 Tesla. Phantom scans were performed to assess the T1 time accuracy. In vivo black-blood and conventional SAPPHIRE T1 mapping was performed in eight healthy subjects and analyzed for T1 times, precision, and inter- and intraobserver variability. Furthermore, manually drawn regions of interest (ROIs) in all T1 maps were dilated and eroded to analyze the dependence of septal T1 times on the ROI thickness. RESULTS: Phantom results and in vivo myocardial T1 times show comparable accuracy with black-blood compared to conventional SAPPHIRE (in vivo: black-blood: 1562 ± 56 ms vs. conventional: 1583 ± 58 ms, P = 0.20); Using black-blood SAPPHIRE precision was significantly lower (standard deviation: 133.9 ± 24.6 ms vs. 63.1 ± 6.4 ms, P < .0001), and blood T1 time measurement was not possible. Significantly increased interobserver interclass correlation coefficient (ICC) (0.996 vs. 0.967, P = 0.011) and similar intraobserver ICC (0.979 vs. 0.939, P = 0.11) was obtained with the black-blood sequence. Conventional SAPPHIRE showed strong dependence on the ROI thickness (R2 = 0.99). No such trend was observed using the black-blood approach (R2 = 0.29). CONCLUSION: Black-blood SAPPHIRE successfully eliminates partial voluming at the blood pool in native myocardial T1 mapping while providing accurate T1 times, albeit at a reduced precision. Magn Reson Med 78:484-493, 2017.
PURPOSE: To study the feasibility of black-blood contrast in native T1 mapping for reduction of partial voluming at the blood-myocardium interface. METHODS: A saturation pulse prepared heart-rate-independent inversion recovery (SAPPHIRE) T1 mapping sequence was combined with motion-sensitized driven-equilibrium (MSDE) blood suppression for black-blood T1 mapping at 3 Tesla. Phantom scans were performed to assess the T1 time accuracy. In vivo black-blood and conventional SAPPHIRE T1 mapping was performed in eight healthy subjects and analyzed for T1 times, precision, and inter- and intraobserver variability. Furthermore, manually drawn regions of interest (ROIs) in all T1 maps were dilated and eroded to analyze the dependence of septal T1 times on the ROI thickness. RESULTS: Phantom results and in vivo myocardial T1 times show comparable accuracy with black-blood compared to conventional SAPPHIRE (in vivo: black-blood: 1562 ± 56 ms vs. conventional: 1583 ± 58 ms, P = 0.20); Using black-blood SAPPHIRE precision was significantly lower (standard deviation: 133.9 ± 24.6 ms vs. 63.1 ± 6.4 ms, P < .0001), and blood T1 time measurement was not possible. Significantly increased interobserver interclass correlation coefficient (ICC) (0.996 vs. 0.967, P = 0.011) and similar intraobserver ICC (0.979 vs. 0.939, P = 0.11) was obtained with the black-blood sequence. Conventional SAPPHIRE showed strong dependence on the ROI thickness (R2 = 0.99). No such trend was observed using the black-blood approach (R2 = 0.29). CONCLUSION: Black-blood SAPPHIRE successfully eliminates partial voluming at the blood pool in native myocardial T1 mapping while providing accurate T1 times, albeit at a reduced precision. Magn Reson Med 78:484-493, 2017.
Authors: Taigang He; Peter D Gatehouse; Paul Kirk; Mark A Tanner; Gillian C Smith; Jennifer Keegan; Raad H Mohiaddin; Dudley J Pennell; David N Firmin Journal: J Magn Reson Imaging Date: 2007-06 Impact factor: 4.813
Authors: Kelvin Chow; Jacqueline A Flewitt; Jordin D Green; Joseph J Pagano; Matthias G Friedrich; Richard B Thompson Journal: Magn Reson Med Date: 2013-07-23 Impact factor: 4.668
Authors: Bram F Coolen; Tessa Geelen; Leonie E M Paulis; Arno Nauerth; Klaas Nicolay; Gustav J Strijkers Journal: NMR Biomed Date: 2010-10-19 Impact factor: 4.044
Authors: Sairia Dass; Joseph J Suttie; Stefan K Piechnik; Vanessa M Ferreira; Cameron J Holloway; Rajarshi Banerjee; Masliza Mahmod; Lowri Cochlin; Theodoros D Karamitsos; Matthew D Robson; Hugh Watkins; Stefan Neubauer Journal: Circ Cardiovasc Imaging Date: 2012-10-15 Impact factor: 7.792
Authors: Sebastian Weingärtner; Steen Moeller; Sebastian Schmitter; Edward Auerbach; Peter Kellman; Chetan Shenoy; Mehmet Akçakaya Journal: Magn Reson Med Date: 2017-06-05 Impact factor: 4.668
Authors: Mashael Alfarih; João B Augusto; Kristopher D Knott; Nasri Fatih; M Praveen Kumar; Redha Boubertakh; Alun D Hughes; James C Moon; Sebastian Weingärtner; Gabriella Captur Journal: BMC Med Imaging Date: 2022-07-07 Impact factor: 2.795
Authors: Sebastian Weingartner; Omer Burak Demirel; Chetan Shenoy; Lothar R Schad; Jeanette Schulz-Menger; Mehmet Akcakaya Journal: Conf Proc IEEE Eng Med Biol Soc Date: 2019-07
Authors: Dina Radenkovic; Sebastian Weingärtner; Lewis Ricketts; James C Moon; Gabriella Captur Journal: Heart Fail Rev Date: 2017-07 Impact factor: 4.214
Authors: Nadja M Meßner; Johannes Budjan; Dirk Loßnitzer; Theano Papavassiliu; Lothar R Schad; Sebastian Weingärtner; Frank G Zöllner Journal: Sci Rep Date: 2018-03-27 Impact factor: 4.379